Twist Bioscience Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Twist Bioscience Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2018 to Q3 2023.
  • Twist Bioscience Corp Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2023 was $302M, a 25.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $302M +$61.7M +25.6% Sep 30, 2023 10-K 2023-11-21
Q3 2022 $241M +$50.2M +26.4% Sep 30, 2022 10-K 2023-11-21
Q3 2021 $190M +$63.1M +49.5% Sep 30, 2021 10-K/A 2023-06-05
Q3 2020 $127M +$42.7M +50.5% Sep 30, 2020 10-K 2021-11-23
Q3 2019 $84.6M +$28.4M +50.6% Sep 30, 2019 10-K 2020-11-27
Q3 2018 $56.2M Sep 30, 2018 10-K 2019-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.